KPTI

Karyopharm Therapeutics Inc.

$9.82 +7.91%

Recent alerts on KPTI

All signals →

News Down -12.14% in 4 Weeks, Here's Why Karyopharm Therapeutics Looks Ripe for a Turnaround

Insider trade Sale by Rangwala Reshma (EVP & Chief Medical Officer)

Insider trade Sale by Poulton Stuart (EVP, Chief Development Officer)

Insider trade Sale by Cheng Sohanya Roshan (EVP & Chief Commercial Officer)

Insider trade Sale by Mano Michael (EVP, CLO&Secretary)

Insider trade Sale by Paulson Richard A. (President and CEO)

Insider trade Sale by Abate Kristin (Chief Accounting Officer)

News Karyopharm outlines $130M-$150M 2026 revenue outlook as it prepares mid-2026 XPORT-EC-042 readout

SEC filing KPTI Q1 2026 Revenue $35.1M, XPOVIO Net $29.2M, Guides FY2026 $130-150M

Insider trade Sale by Reshma Rangwala (EVP & Chief Medical Officer)

Insider trade Sale by Reshma Rangwala (EVP & Chief Medical Officer)

News Karyopharm Therapeutics jumps 18%, raises $30M privately

News Karyopharm to seek label expansion for Xpovio in myelofibrosis after late-stage trial win

SEC filing KPTI Reports $120M Revenue, $0.15 EPS, +150% YoY, Announces $500M Buyback, FDA Meeting Planned

Insider trade Sale by Michael Mano (EVP, CLO&Secretary)

Insider trade Sale by Richard A. Paulson (President and CEO)

Insider trade Sale by Reshma Rangwala (EVP & Chief Medical Officer)

Insider trade Sale by Lori Macomber (EVP, CFO & Treasurer)

Insider trade Sale by Kristin Abate

Insider trade Sale by Kristin Abate (Chief Accounting Officer)

Earnings Results Earnings Results

News Karyopharm signals $130M–$150M revenue target for 2026 with pivotal myelofibrosis data readout ahead

News Software Stocks Sell-Off: Are They Deals or Traps? - Zacks Investment Research

News OXFORD BANK CORPORATION ANNOUNCES FOURTH QUARTER AND FULL YEAR 2025 OPERATING RESULTS

News Richmond Fed Manufacturing ticks up, stays negative in January

Get push alerts for KPTI

Add it to your watchlist in the app and receive every signal the moment it fires.

Download for iOS

Download for iOS